Christopher F. Wyatt - 30 Jan 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP & Controller
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
30 Jan 2023
Transactions value $
-$1,907,393
Form type
4
Filing time
01 Feb 2023, 19:08:13 UTC
Previous filing
23 Feb 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $984K +12K +37.29% $81.96 44.2K 30 Jan 2023 Direct
transaction HCA Common Stock Tax liability -$1.65M -6.51K -14.74% $253.30 37.7K 30 Jan 2023 Direct
transaction HCA Common Stock Gift $0 -379 -1.01% $0.00 37.3K 31 Jan 2023 Direct
transaction HCA Common Stock Sale -$1.24M -4.9K -13.14% $253.30 32.4K 01 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -12K -81.74% $0.00 2.68K 30 Jan 2023 Common Stock 12K $81.96 Direct F1
transaction HCA Stock Appreciation Right Award $0 +5.05K $0.00 5.05K 30 Jan 2023 Common Stock 5.05K $253.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
F2 The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024.